-
1
-
-
47249087287
-
Polycystic ovary syndrome in adolescents
-
Franks S. Polycystic ovary syndrome in adolescents. Int J Obes (Lond) 32 (2008) 1035-1041
-
(2008)
Int J Obes (Lond)
, vol.32
, pp. 1035-1041
-
-
Franks, S.1
-
2
-
-
4043063685
-
Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome
-
Dhindsa G., Bhatia R., Dhindsa M., and Bhatia V. Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome. J Postgrad Med 50 (2004) 140-144
-
(2004)
J Postgrad Med
, vol.50
, pp. 140-144
-
-
Dhindsa, G.1
Bhatia, R.2
Dhindsa, M.3
Bhatia, V.4
-
3
-
-
38149113967
-
Statins in the treatment of polycystic ovary syndrome
-
Kodaman P.H., and Duleba A.J. Statins in the treatment of polycystic ovary syndrome. Semin Reprod Med 26 (2008) 127-138
-
(2008)
Semin Reprod Med
, vol.26
, pp. 127-138
-
-
Kodaman, P.H.1
Duleba, A.J.2
-
4
-
-
38149082597
-
Cardiovascular disease risk factors in polycystic ovary syndrome
-
Dokras A. Cardiovascular disease risk factors in polycystic ovary syndrome. Semin Reprod Med 26 (2008) 39-44
-
(2008)
Semin Reprod Med
, vol.26
, pp. 39-44
-
-
Dokras, A.1
-
5
-
-
0346725827
-
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
-
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
-
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
-
(2004)
Fertil Steril
, vol.81
, pp. 19-25
-
-
-
6
-
-
21244477098
-
Screening women with polycystic ovary syndrome for metabolic syndrome
-
Dokras A., Bochner M., Hollinrake E., Markham S., Vanvoorhis B., and Jagasia D.H. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol 106 (2005) 131-137
-
(2005)
Obstet Gynecol
, vol.106
, pp. 131-137
-
-
Dokras, A.1
Bochner, M.2
Hollinrake, E.3
Markham, S.4
Vanvoorhis, B.5
Jagasia, D.H.6
-
7
-
-
35448985807
-
Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome
-
Guzelmeric K., Alkan N., Pirimoglu M., Unal O., and Turan C. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome. Gynecol Endocrinol 23 (2007) 505-510
-
(2007)
Gynecol Endocrinol
, vol.23
, pp. 505-510
-
-
Guzelmeric, K.1
Alkan, N.2
Pirimoglu, M.3
Unal, O.4
Turan, C.5
-
8
-
-
33745621423
-
Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin
-
Diamanti-Kandarakis E., Paterakis T., Alexandraki K., Piperi C., Aessopos A., Katsikis I., et al. Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin. Hum Reprod 21 (2006) 1426-1431
-
(2006)
Hum Reprod
, vol.21
, pp. 1426-1431
-
-
Diamanti-Kandarakis, E.1
Paterakis, T.2
Alexandraki, K.3
Piperi, C.4
Aessopos, A.5
Katsikis, I.6
-
9
-
-
2542460047
-
The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL
-
Navab M., Ananthramaiah G.M., Reddy S.T., Van Lenten B.J., Ansell B.J., Fonarow G.C., et al. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res 45 (2004) 993-1007
-
(2004)
J Lipid Res
, vol.45
, pp. 993-1007
-
-
Navab, M.1
Ananthramaiah, G.M.2
Reddy, S.T.3
Van Lenten, B.J.4
Ansell, B.J.5
Fonarow, G.C.6
-
10
-
-
33750943178
-
Clinical aspects of plasma platelet-activating factor-acetylhydrolase
-
Karasawa K. Clinical aspects of plasma platelet-activating factor-acetylhydrolase. Biochim Biophys Acta 1761 (2006) 1359-1372
-
(2006)
Biochim Biophys Acta
, vol.1761
, pp. 1359-1372
-
-
Karasawa, K.1
-
11
-
-
2642567931
-
Platelet-activating factor acetylhydrolase: is it good or bad for you?
-
Chen C.H. Platelet-activating factor acetylhydrolase: is it good or bad for you?. Curr Opin Lipidol 15 (2004) 337-341
-
(2004)
Curr Opin Lipidol
, vol.15
, pp. 337-341
-
-
Chen, C.H.1
-
12
-
-
0042125177
-
Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease
-
Caslake M.J., and Packard C.J. Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease. Curr Opin Lipidol 14 (2003) 347-352
-
(2003)
Curr Opin Lipidol
, vol.14
, pp. 347-352
-
-
Caslake, M.J.1
Packard, C.J.2
-
13
-
-
33846635122
-
Ratio of LDL- to HDL-associated platelet-activating factor acetylhydrolase may be a marker of inflammation in patients with paroxysmal atrial fibrillation
-
Okamura K., Miura S., Zhang B., Uehara Y., Matsuo K., Kumagai K., et al. Ratio of LDL- to HDL-associated platelet-activating factor acetylhydrolase may be a marker of inflammation in patients with paroxysmal atrial fibrillation. Circ J 71 (2007) 214-219
-
(2007)
Circ J
, vol.71
, pp. 214-219
-
-
Okamura, K.1
Miura, S.2
Zhang, B.3
Uehara, Y.4
Matsuo, K.5
Kumagai, K.6
-
14
-
-
0021813187
-
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
-
Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
-
(1985)
Diabetologia
, vol.28
, pp. 412-419
-
-
Matthews, D.R.1
Hosker, J.P.2
Rudenski, A.S.3
Naylor, B.A.4
Treacher, D.F.5
Turner, R.C.6
-
15
-
-
33646432490
-
Modulating effects of cholesterol feeding and simvastatin treatment on platelet-activating factor acetylhydrolase activity and lysophosphatidylcholine concentration
-
Zhang B., Fan P., Shimoji E., Itabe H., Miura S., Uehara Y., et al. Modulating effects of cholesterol feeding and simvastatin treatment on platelet-activating factor acetylhydrolase activity and lysophosphatidylcholine concentration. Atherosclerosis 186 (2006) 291-301
-
(2006)
Atherosclerosis
, vol.186
, pp. 291-301
-
-
Zhang, B.1
Fan, P.2
Shimoji, E.3
Itabe, H.4
Miura, S.5
Uehara, Y.6
-
16
-
-
0036186708
-
Altered distribution of platelet-activating factor-acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia
-
Tsimihodimos V., Karabina S.A., Tambaki A.P., Bairaktari E., Miltiadous G., Goudevenos J.A., et al. Altered distribution of platelet-activating factor-acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia. J Lipid Res 43 (2002) 256-263
-
(2002)
J Lipid Res
, vol.43
, pp. 256-263
-
-
Tsimihodimos, V.1
Karabina, S.A.2
Tambaki, A.P.3
Bairaktari, E.4
Miltiadous, G.5
Goudevenos, J.A.6
-
17
-
-
0242408854
-
Effect of hypolipidemic drugs on lipoprotein-associated platelet activating factor acetylhydrolase. Implication for atherosclerosis
-
Eisaf M., and Tselepis A.D. Effect of hypolipidemic drugs on lipoprotein-associated platelet activating factor acetylhydrolase. Implication for atherosclerosis. Biochem Pharmacol 66 (2003) 2069-2073
-
(2003)
Biochem Pharmacol
, vol.66
, pp. 2069-2073
-
-
Eisaf, M.1
Tselepis, A.D.2
|